Understanding the complex science that lies at the heart of a biotech company is what we do. Our team excels in telling complex scientific stories to the financial and investor community as well as the business and science press in an impactful way. From early clinical development to drug approvals, we support our clients through development and commercialisation. Just ask us about our work with Advaxis, Intercept Pharmaceuticals and Mateon Therapeutics.
